Profile
Christopher R.
Heery worked as Head-Clinical Trials at the National Cancer Institute from 2013 to 2016.
Served as Chief Medical Officer at Bavarian Nordic A from 2016 to 2019.
Served as Chief Medical Officer at Precision BioSciences, Inc. from 2019 to 2021.
Served as Chief Medical Officer at Arcellx, Inc. from 2021 to 2026.
Completed undergraduate studies at Duke University.
Earned a doctorate from Brody School of Medicine in 2006.
Former positions of Christopher Heery
| Companies | Position | End |
|---|---|---|
| ARCELLX, INC. | Chief Tech/Sci/R&D Officer | 2026-04-27 |
| PRECISION BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | 2021-04-22 |
| BAVARIAN NORDIC A/S | Chief Tech/Sci/R&D Officer | 2019-03-31 |
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous Conducts research projects & awards grants for cancer research | Corporate Officer/Principal | 2016-08-31 |
Training of Christopher Heery
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Precision BioSciences, Inc.
Precision BioSciences, Inc. BiotechnologyHealth Technology Develops technology to produce custom, genome-editing enzymes for human health and biological research | Health Technology |
Duke University
Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bavarian Nordic A/S
Bavarian Nordic A/S BiotechnologyHealth Technology Engages in research, development and manufacturing travel vaccines | Health Technology |
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous Conducts research projects & awards grants for cancer research | Miscellaneous |
Brody School of Medicine
Brody School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Arcellx, Inc.
Arcellx, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company reimagining cell therapy through the development of innovative immunotherapies | Health Technology |
- Stock Market
- Insiders
- Christopher Heery
















